Clinical Grants Expenditures are on the Rise Throughout the WorldByTTCOctober 1st 2010Clinical grant expenditures represent a major portion of the budget for later phase clinical trials.
Is It Safe to Outsource Safety?ByGraeme LaddsOctober 1st 2010Knowing when to outsource and when to conduct pharmacovigilance in-house is a crucial decision.
Does Your Overseas R&D Organization Comply With the US FCPA?ByTed Acosta,Eileen ErdosSeptember 29th 2010
Second Edition of User’s Guide for Patient Registry Development Published by Agency for Healthcare Research and QualitySeptember 27th 2010
Almac’s Clinical Technologies Division Undergoes Successful Joint GCP-GMP MHRA InspectionSeptember 21st 2010
Parexel Announces Strategic Functional Service Provider Relationship With Eli Lilly and Company for Clinical Development in Asia/Pacific RegionSeptember 21st 2010
The Open Source Effect: Akaza Research Provides Insight into Rapid Growth of OpenClinicaSeptember 17th 2010
Clearstone Reporting HbA1c Result Values in IFCC and NGSP Units for All Clinical Trials GloballySeptember 16th 2010
Ricerca Biosciences/Instem Collaboration Delivers Improved Quality in Drug Safety StudiesSeptember 14th 2010
Changing Relationships Between Pharmaceutical Companies and Their Outsourced ProvidersSeptember 13th 2010